Zhonghua yi xue za zhi, ISSN 0376-2491, 07/2017, Volume 97, Issue 27, pp. 2087 - 2090
Journal Article
Muscle & Nerve, ISSN 0148-639X, 07/2019, Volume 60, Issue 1, pp. 14 - 24
ABSTRACT Introduction: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody‐positive refractory generalized...
MGC | myasthenia gravis | MG‐ADL | eculizumab | QMG | MG‐QOL15 | MG-ADL | MG-QOL15 | COMPLEMENT INHIBITOR ECULIZUMAB | ANTIBODY | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | CLINICAL NEUROLOGY | THERAPY | DOUBLE-BLIND | Effectiveness | Activities of daily living | Antibodies | Muscles | Pharmacology | Quality of life | Refractory materials | Myasthenia gravis | Neuromuscular junctions | Remission | Myasthenia | Safety | Muscular strength | Clinical | Clinical s
MGC | myasthenia gravis | MG‐ADL | eculizumab | QMG | MG‐QOL15 | MG-ADL | MG-QOL15 | COMPLEMENT INHIBITOR ECULIZUMAB | ANTIBODY | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | CLINICAL NEUROLOGY | THERAPY | DOUBLE-BLIND | Effectiveness | Activities of daily living | Antibodies | Muscles | Pharmacology | Quality of life | Refractory materials | Myasthenia gravis | Neuromuscular junctions | Remission | Myasthenia | Safety | Muscular strength | Clinical | Clinical s
Journal Article
Muscle & Nerve, ISSN 0148-639X, 04/2014, Volume 49, Issue 4, pp. 483 - 486
ABSTRACT Introduction: The objective of this study is to determine if change in acetylcholine receptor antibody (AChR‐ab) levels reflects change in clinical...
myasthenia gravis | clinical trials | outcome measures | acetylcholine receptor antibody | QMG score | MG Composite | Clinical trials | Outcome measures | MG composite | Myasthenia gravis | Acetylcholine receptor antibody | OUTCOME MEASURE | SCORE | THYMECTOMY | NEUROSCIENCES | CLINICAL NEUROLOGY | Prospective Studies | Myasthenia Gravis - blood | Autoantibodies - blood | Humans | Myasthenia Gravis - therapy | Registries | Databases, Factual - trends | Biomarkers - blood | Myasthenia Gravis - diagnosis | Receptors, Cholinergic - blood | Cohort Studies | Viral antibodies | Antibodies
myasthenia gravis | clinical trials | outcome measures | acetylcholine receptor antibody | QMG score | MG Composite | Clinical trials | Outcome measures | MG composite | Myasthenia gravis | Acetylcholine receptor antibody | OUTCOME MEASURE | SCORE | THYMECTOMY | NEUROSCIENCES | CLINICAL NEUROLOGY | Prospective Studies | Myasthenia Gravis - blood | Autoantibodies - blood | Humans | Myasthenia Gravis - therapy | Registries | Databases, Factual - trends | Biomarkers - blood | Myasthenia Gravis - diagnosis | Receptors, Cholinergic - blood | Cohort Studies | Viral antibodies | Antibodies
Journal Article
Muscle & Nerve, ISSN 0148-639X, 05/2019, Volume 59, Issue 5, pp. 583 - 586
ABSTRACT Introduction We translated the myasthenia gravis (MG)‐specific activities of daily living (MG‐ADL) scale into Arabic (MG‐ADL‐A) and assessed its...
MGQOL15R | MG‐ADL | Arabic | outcome measure | activities of daily living | myasthenia gravis | MG‐ADL‐A | MGQOL15 | MG-ADL | MG-ADL-A | QMG | NEUROSCIENCES | CLINICAL NEUROLOGY | Medical colleges | Myasthenia gravis | Activities of daily living | Translating and interpreting | Analysis | Correlation coefficient | Sensitivity analysis | Correlation coefficients | Muscles | Patients | Rank tests | Reproducibility | MMT | Reliability analysis | Neuromuscular junctions | Myasthenia | Quantitative psychology
MGQOL15R | MG‐ADL | Arabic | outcome measure | activities of daily living | myasthenia gravis | MG‐ADL‐A | MGQOL15 | MG-ADL | MG-ADL-A | QMG | NEUROSCIENCES | CLINICAL NEUROLOGY | Medical colleges | Myasthenia gravis | Activities of daily living | Translating and interpreting | Analysis | Correlation coefficient | Sensitivity analysis | Correlation coefficients | Muscles | Patients | Rank tests | Reproducibility | MMT | Reliability analysis | Neuromuscular junctions | Myasthenia | Quantitative psychology
Journal Article
EBioMedicine, ISSN 2352-3964, 02/2018, Volume 28, Issue C, pp. 143 - 150
It is a continuous matter of discussion whether immune activation by vaccination in general and Influenza vaccination in particular increases the risk for...
Autoimmune myasthenia gravis | Acetylcholine receptor antibody titer | Randomized controlled trial | Vaccination | QMG score
Autoimmune myasthenia gravis | Acetylcholine receptor antibody titer | Randomized controlled trial | Vaccination | QMG score
Journal Article
Journal of Silk, ISSN 1001-7003, 05/2018, Volume 55, Issue 5, pp. 91 - 95
Journal Article
Superconductor Science and Technology, ISSN 0953-2048, 01/2016, Volume 29, Issue 3, pp. 34002 - 34010
This paper describes the progress in quench melt-growth. (QMG) bulk magnets, developed by. the Nippon Steel & Sumitomo Metal Corporation, which consist. of...
RE-Ba-Cu-O | NMR | trapped magnetic field | melt-growth | QMG | bulk | magnet | TRAPPED FIELD | PHYSICS, CONDENSED MATTER | BA-CU-O | PHYSICS, APPLIED | CRITICAL-CURRENT DENSITY | REFINEMENT | SUPERCONDUCTING PROPERTIES | Superconductors | Spectrometers | Homogeneity | Flywheels | Nuclear magnetic resonance | Magnetic fields | Magnets | Optimization
RE-Ba-Cu-O | NMR | trapped magnetic field | melt-growth | QMG | bulk | magnet | TRAPPED FIELD | PHYSICS, CONDENSED MATTER | BA-CU-O | PHYSICS, APPLIED | CRITICAL-CURRENT DENSITY | REFINEMENT | SUPERCONDUCTING PROPERTIES | Superconductors | Spectrometers | Homogeneity | Flywheels | Nuclear magnetic resonance | Magnetic fields | Magnets | Optimization
Journal Article
IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY, ISSN 1051-8223, 04/2016, Volume 26, Issue 3
High-temperature superconducting (HTS) bulk materials of RE-Ba-Cu-O (RE: Y or rare-earth elements) exhibit excellent J(c)-B properties, even at 77 K, leading...
RE-Ba-Cu-O | SYSTEM | PHYSICS, APPLIED | high-temperature superconductors (HTS) | MAGNETIZATION | Bulk superconductors | current leads | QMG | superconducting devices | ENGINEERING, ELECTRICAL & ELECTRONIC
RE-Ba-Cu-O | SYSTEM | PHYSICS, APPLIED | high-temperature superconductors (HTS) | MAGNETIZATION | Bulk superconductors | current leads | QMG | superconducting devices | ENGINEERING, ELECTRICAL & ELECTRONIC
Journal Article
EBIOMEDICINE, ISSN 2352-3964, 02/2018, Volume 28, pp. 143 - 150
Background: It is a continuousmatter of discussionwhether immune activation by vaccination in general and Influenza vaccination in particular increases the...
MEDICINE, RESEARCH & EXPERIMENTAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | EFFICACY | SAFETY | Vaccination | QMG score | Autoimmune myasthenia gravis | Randomized controlled trial | IMMUNIZATION | MULTIPLE-SCLEROSIS | DISEASE | CRISIS | BOOSTER | Acetylcholine receptor antibody titer | VACCINES
MEDICINE, RESEARCH & EXPERIMENTAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | EFFICACY | SAFETY | Vaccination | QMG score | Autoimmune myasthenia gravis | Randomized controlled trial | IMMUNIZATION | MULTIPLE-SCLEROSIS | DISEASE | CRISIS | BOOSTER | Acetylcholine receptor antibody titer | VACCINES
Journal Article
Journal of Neurology, ISSN 0340-5354, 1/2016, Volume 263, Issue 1, pp. 83 - 88
Leflunomide is an effective drug used in the treatment of rheumatoid arthritis. Here we report the findings of an open-label pilot study, which found that...
Neurology | Neurosciences | Corticosteroid-dependent | Myasthenia gravis | Medicine & Public Health | ADL | QMG | Leflunomide | Neuroradiology | RHEUMATOID-ARTHRITIS | RELAPSING MULTIPLE-SCLEROSIS | SAFETY | RANDOMIZED-TRIAL | ORAL TERIFLUNOMIDE | LOW-DOSE TACROLIMUS | CLINICAL NEUROLOGY | PREDNISONE | DOUBLE-BLIND | MYCOPHENOLATE-MOFETIL | CYCLOSPORINE | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Isoxazoles - administration & dosage | Activities of Daily Living | Isoxazoles - pharmacology | Young Adult | Pilot Projects | Adolescent | Glucocorticoids - pharmacology | Adult | Female | Prednisone - pharmacology | Drug Therapy, Combination | Immunosuppressive Agents - pharmacology | Myasthenia Gravis - drug therapy | Immunosuppressive Agents - administration & dosage | Complications and side effects | Care and treatment | Patient outcomes | Development and progression | Research
Neurology | Neurosciences | Corticosteroid-dependent | Myasthenia gravis | Medicine & Public Health | ADL | QMG | Leflunomide | Neuroradiology | RHEUMATOID-ARTHRITIS | RELAPSING MULTIPLE-SCLEROSIS | SAFETY | RANDOMIZED-TRIAL | ORAL TERIFLUNOMIDE | LOW-DOSE TACROLIMUS | CLINICAL NEUROLOGY | PREDNISONE | DOUBLE-BLIND | MYCOPHENOLATE-MOFETIL | CYCLOSPORINE | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Isoxazoles - administration & dosage | Activities of Daily Living | Isoxazoles - pharmacology | Young Adult | Pilot Projects | Adolescent | Glucocorticoids - pharmacology | Adult | Female | Prednisone - pharmacology | Drug Therapy, Combination | Immunosuppressive Agents - pharmacology | Myasthenia Gravis - drug therapy | Immunosuppressive Agents - administration & dosage | Complications and side effects | Care and treatment | Patient outcomes | Development and progression | Research
Journal Article
IEEE Transactions on Applied Superconductivity, ISSN 1051-8223, 04/2016, Volume 26, Issue 3, pp. 1 - 4
This paper describes the recent progress in QMG bulks in Nippon Steel and Sumitomo Metal Corporation. QMG is a high-Jc bulk material, which consists of a...
RE-Ba-Cu-O | High-temperature superconductors | Magnetic field measurement | Shape | Melt-growth | Crystals | Bulk superconductor | Superconducting magnets | QMG | Nuclear magnetic resonance | Trapped magnetic field | Magnetic fields | TRAPPED FIELD | CURRENT LEADS | trapped magnetic field | BA-CU-O | PHYSICS, APPLIED | melt-growth | SUPERCONDUCTING PROPERTIES | ENGINEERING, ELECTRICAL & ELECTRONIC | Nuclear magnetic resonance--NMR
RE-Ba-Cu-O | High-temperature superconductors | Magnetic field measurement | Shape | Melt-growth | Crystals | Bulk superconductor | Superconducting magnets | QMG | Nuclear magnetic resonance | Trapped magnetic field | Magnetic fields | TRAPPED FIELD | CURRENT LEADS | trapped magnetic field | BA-CU-O | PHYSICS, APPLIED | melt-growth | SUPERCONDUCTING PROPERTIES | ENGINEERING, ELECTRICAL & ELECTRONIC | Nuclear magnetic resonance--NMR
Journal Article
IEEE Transactions on Applied Superconductivity, ISSN 1051-8223, 04/2016, Volume 26, Issue 3, pp. 1 - 4
High-temperature superconducting (HTS) bulk materials of RE-Ba-Cu-O (RE: Y or rare-earth elements) exhibit excellent J c properties, even at 77 K, leading to...
High-temperature superconductors | Current leads | Superconducting magnets | Conductivity | Bulk superconductors | Thermal conductivity | Robustness | Yttrium | Hightemperature superconductors | Thermal stresses | RE-Ba-Cu-O | current leads | QMG | hightemperature superconductors (HTS) | superconducting devices | SYSTEM | PHYSICS, APPLIED | high-temperature superconductors (HTS) | MAGNETIZATION | ENGINEERING, ELECTRICAL & ELECTRONIC
High-temperature superconductors | Current leads | Superconducting magnets | Conductivity | Bulk superconductors | Thermal conductivity | Robustness | Yttrium | Hightemperature superconductors | Thermal stresses | RE-Ba-Cu-O | current leads | QMG | hightemperature superconductors (HTS) | superconducting devices | SYSTEM | PHYSICS, APPLIED | high-temperature superconductors (HTS) | MAGNETIZATION | ENGINEERING, ELECTRICAL & ELECTRONIC
Journal Article
Muscle & Nerve, ISSN 0148-639X, 09/2017, Volume 56, Issue 3, pp. 445 - 448
ABSTRACT Introduction Electrophysiological studies play an important role in the diagnosis of myasthenia gravis (MG). The objectives of this study was to...
myasthenia gravis | disease severity | QMGS | optimal thresholds | single fiber EMG | repetitive nerve stimulation | DOUBLE-BLIND | RELIABILITY | NEUROSCIENCES | CLINICAL NEUROLOGY | Severity of Illness Index | Humans | Middle Aged | Electrophysiological Phenomena - physiology | Male | Myasthenia Gravis - diagnosis | Myasthenia Gravis - physiopathology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Electromyography - methods | Travel | Myasthenia gravis | Vibration | Thresholds | Correlation analysis | Neuromuscular junctions | Myasthenia | Diagnosis | Patients
myasthenia gravis | disease severity | QMGS | optimal thresholds | single fiber EMG | repetitive nerve stimulation | DOUBLE-BLIND | RELIABILITY | NEUROSCIENCES | CLINICAL NEUROLOGY | Severity of Illness Index | Humans | Middle Aged | Electrophysiological Phenomena - physiology | Male | Myasthenia Gravis - diagnosis | Myasthenia Gravis - physiopathology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Electromyography - methods | Travel | Myasthenia gravis | Vibration | Thresholds | Correlation analysis | Neuromuscular junctions | Myasthenia | Diagnosis | Patients
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2015, Volume 358, Issue 1, pp. 101 - 106
Abstract Background Myasthenia gravis (MG) is the autoimmune disorder in which the thymus is considered the pathogenic organ. Thymectomy (TE) is a therapeutic...
Neurology | Myasthenia gravis | Thymectomy | Corticosteroids | Combined immunosuppressive treatment | CD4+ CD25+ regulatory T-lymphocytes | QMG score | Pyridostigmine | CD4 + CD25 + regulatory T-lymphocytes | CD4(+) CD25(+) regulatory T-lymphocytes | DENDRITIC CELLS | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | CLINICAL NEUROLOGY | B-CELLS | THYMUS | THERAPY | CD4(+)CD25(+) | DISEASE | CD4(+) | GENERATION | IMMUNE TOLERANCE | Interleukin-2 Receptor alpha Subunit | Follow-Up Studies | Myasthenia Gravis - blood | Outcome Assessment (Health Care) | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | CD4 Antigens | Male | CD4 Lymphocyte Count | Combined Modality Therapy | Adrenal Cortex Hormones - therapeutic use | Young Adult | Thymectomy - methods | Lymphocyte Count | T-Lymphocytes, Regulatory | Adult | Female | Drug Therapy, Combination | Myasthenia Gravis - drug therapy | Myasthenia Gravis - surgery | T cells
Neurology | Myasthenia gravis | Thymectomy | Corticosteroids | Combined immunosuppressive treatment | CD4+ CD25+ regulatory T-lymphocytes | QMG score | Pyridostigmine | CD4 + CD25 + regulatory T-lymphocytes | CD4(+) CD25(+) regulatory T-lymphocytes | DENDRITIC CELLS | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | CLINICAL NEUROLOGY | B-CELLS | THYMUS | THERAPY | CD4(+)CD25(+) | DISEASE | CD4(+) | GENERATION | IMMUNE TOLERANCE | Interleukin-2 Receptor alpha Subunit | Follow-Up Studies | Myasthenia Gravis - blood | Outcome Assessment (Health Care) | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | CD4 Antigens | Male | CD4 Lymphocyte Count | Combined Modality Therapy | Adrenal Cortex Hormones - therapeutic use | Young Adult | Thymectomy - methods | Lymphocyte Count | T-Lymphocytes, Regulatory | Adult | Female | Drug Therapy, Combination | Myasthenia Gravis - drug therapy | Myasthenia Gravis - surgery | T cells
Journal Article
Muscle & Nerve, ISSN 0148-639X, 05/2014, Volume 49, Issue 5, pp. 661 - 665
ABSTRACT Introduction: The minimal clinically important difference (MCID) is the smallest outcome change that has clinical significance. Its use has not been...
myasthenia gravis | MCID | neuromuscular junction | outcomes | QMGS | Myasthenia gravis | Neuromuscular junction | Outcomes | DISEASE | IMMUNOGLOBULIN | QUALITY-OF-LIFE | NEUROSCIENCES | CLINICAL NEUROLOGY | Humans | Middle Aged | Male | Treatment Outcome | Myasthenia Gravis - diagnosis | Immunoglobulins, Intravenous - therapeutic use | Female | ROC Curve | Surveys and Questionnaires | Electromyography | Clinical Trials as Topic - methods | Myasthenia Gravis - drug therapy | Immunologic Factors - therapeutic use | Analysis
myasthenia gravis | MCID | neuromuscular junction | outcomes | QMGS | Myasthenia gravis | Neuromuscular junction | Outcomes | DISEASE | IMMUNOGLOBULIN | QUALITY-OF-LIFE | NEUROSCIENCES | CLINICAL NEUROLOGY | Humans | Middle Aged | Male | Treatment Outcome | Myasthenia Gravis - diagnosis | Immunoglobulins, Intravenous - therapeutic use | Female | ROC Curve | Surveys and Questionnaires | Electromyography | Clinical Trials as Topic - methods | Myasthenia Gravis - drug therapy | Immunologic Factors - therapeutic use | Analysis
Journal Article
Journal of Clinical Neurophysiology, ISSN 0736-0258, 09/2017, Volume 34, Issue 5, pp. 408 - 412
PURPOSE:Our aim in the current study was to determine the minimum number of SFEMG potential pairs required to confirm neuromuscular junction impairment and...
Disease severity | Single-fiber EMG | Myasthenia gravis | Pairs | QMGS | ACTIVATION | SCORE | MUSCLE | RELIABILITY | SINGLE-FIBER ELECTROMYOGRAPHY | NEUROSCIENCES | CLINICAL NEUROLOGY | JITTER | EMG | Severity of Illness Index | Humans | Middle Aged | Male | Neuromuscular Junction - physiopathology | Myasthenia Gravis - diagnosis | Facial Muscles - physiopathology | Myasthenia Gravis - physiopathology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Electromyography - methods
Disease severity | Single-fiber EMG | Myasthenia gravis | Pairs | QMGS | ACTIVATION | SCORE | MUSCLE | RELIABILITY | SINGLE-FIBER ELECTROMYOGRAPHY | NEUROSCIENCES | CLINICAL NEUROLOGY | JITTER | EMG | Severity of Illness Index | Humans | Middle Aged | Male | Neuromuscular Junction - physiopathology | Myasthenia Gravis - diagnosis | Facial Muscles - physiopathology | Myasthenia Gravis - physiopathology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Electromyography - methods
Journal Article
Muscle & Nerve, ISSN 0148-639X, 02/2018, Volume 57, Issue 2, pp. 240 - 244
ABSTRACT Introduction: Assessing myasthenia gravis (MG) can be challenging, and multiple scales are available to evaluate disease severity. We evaluated the...
myasthenia gravis | percentage of normal | grip | MG‐QOL15 | QMGS | MGII | MG-QOL15 | FIBROSIS | DIAGNOSIS | BLOOD-FLOW | NEUROSCIENCES | EXERCISE | CLINICAL NEUROLOGY | DIABETES-MELLITUS | SKELETAL-MUSCLE | PRESSURE | FIBER TYPES | EXERTIONAL COMPARTMENT SYNDROME | CONNECTIVE-TISSUE | Disability Evaluation | Muscle Weakness - etiology | Ocular Motility Disorders - etiology | Follow-Up Studies | Myasthenia Gravis - psychology | Humans | Middle Aged | Male | Muscle Weakness - psychology | Myasthenia Gravis - diagnosis | Blepharoptosis - psychology | Blepharoptosis - etiology | Electrodiagnosis | Myasthenia Gravis - physiopathology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Retrospective Studies | Longitudinal Studies | Ocular Motility Disorders - psychology | Cohort Studies | Analysis | Myasthenia gravis | Evaluation | Feasibility studies | Muscles | Neuromuscular junctions | Myasthenia | Patients | Quality of life
myasthenia gravis | percentage of normal | grip | MG‐QOL15 | QMGS | MGII | MG-QOL15 | FIBROSIS | DIAGNOSIS | BLOOD-FLOW | NEUROSCIENCES | EXERCISE | CLINICAL NEUROLOGY | DIABETES-MELLITUS | SKELETAL-MUSCLE | PRESSURE | FIBER TYPES | EXERTIONAL COMPARTMENT SYNDROME | CONNECTIVE-TISSUE | Disability Evaluation | Muscle Weakness - etiology | Ocular Motility Disorders - etiology | Follow-Up Studies | Myasthenia Gravis - psychology | Humans | Middle Aged | Male | Muscle Weakness - psychology | Myasthenia Gravis - diagnosis | Blepharoptosis - psychology | Blepharoptosis - etiology | Electrodiagnosis | Myasthenia Gravis - physiopathology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Retrospective Studies | Longitudinal Studies | Ocular Motility Disorders - psychology | Cohort Studies | Analysis | Myasthenia gravis | Evaluation | Feasibility studies | Muscles | Neuromuscular junctions | Myasthenia | Patients | Quality of life
Journal Article
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, ISSN 1997-7298, 2012, Volume 112, Issue 7, pp. 32 - 35
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 2003, Volume 998, pp. 440 - 444
Manual muscle testing | QMG | Activities of daily living | Scoring systems | Myasthenia gravis (MG) | manual muscle testing | activities of daily living | MULTIDISCIPLINARY SCIENCES | myasthenia gravis (MG) | scoring systems | Severity of Illness Index | Reproducibility of Results | Myasthenia Gravis - physiopathology | Humans | Muscles - physiopathology | Weights and Measures | Linear Models | Myasthenia Gravis - diagnosis | Neurologic Examination - statistics & numerical data
Journal Article
Journal of Neuromuscular Diseases, ISSN 2214-3599, 2015, Volume 2, Issue 3, pp. 301 - 311
The Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite are two commonly used outcome measures in Myasthenia Gravis. So far, their...
MGC | Rasch | Myasthenia gravis | QMGS | Outcome assessment (Health Care)
MGC | Rasch | Myasthenia gravis | QMGS | Outcome assessment (Health Care)
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.